Esperion Therapeutics, Inc.ESPRNASDAQ
Loading
Net Income ScalingExpanding
Percentile Rank86
Studio
Year-over-Year Change

Total earnings after all expenses, taxes, and interest

Latest
$-22.68M
↑ 85% vs avg
Percentile
P86
Within normal range
Streak
4 yr
Consecutive growthExpanding
Average
$-147.09M
Historical baseline
PeriodValueYoY Change
2025$-22.68M+56.2%
2024$-51.74M+75.3%
2023$-209.25M+10.4%
2022$-233.66M+13.2%
2021$-269.11M-87.5%
2020$-143.55M-47.7%
2019$-97.17M+51.9%
2018$-201.81M-20.9%
2017$-166.99M-122.7%
2016$-74.98M-